Public, Academic Labs Press FDA To Be Flexible In LDT Requirements
This article was originally published in The Gray Sheet
Executive Summary
State health and academic labs ask FDA to exercise flexibility in its clinical requirements for laboratory-developed tests and warn against unintended consequences for public health testing.